CRISPR Therapeutics
Could I land a role at this company?
Get your resume score and fixes with refresh.cv.
CRISPR Therapeutics
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in…
Gene Editing
Cell Therapy
Clinical Research
Bioinformatics
Molecular Biology
Open roles at CRISPR Therapeutics
12 open roles
Statistical Programming Contractor (16-Month Contract)
Project Management
South Boston, MA
On-site
Mid Level
Contract
Today
Engineer III, mRNA Process Development-Downstream
Engineering
South Boston, MA
On-site
Mid Level
Full-time
Today
Associate Manager, CMC Operations
Operations
South Boston, MA
On-site
Lead
Full-time
Today
Scientist II, CRISPR-X - Gene Insertion
Operations
South Boston, MA
On-site
Mid Level
Full-time
Today
Senior Manager, Program Management
Project Management
South Boston, MA
On-site
Senior
Full-time
Today
Scientist II, in vivo Gene Insertion
Healthcare
San Francisco, CA
On-site
Mid Level
Full-time
Today
Senior Specialist, Site Supply Chain Planning
Logistics
Framingham, MA
On-site
Senior
Full-time
Today
Executive Director, Clinical Development
Healthcare
South Boston, MA
On-site
Director
Full-time
Today
Executive Director, External Manufacturing & Supply Chain
Logistics
South Boston, MA
On-site
Director
Full-time
Today
Director, LNP Discovery
Healthcare
South Boston, MA
On-site
Director
Full-time
Today
Senior Scientist, Analytical Development
Healthcare
South Boston, MA
On-site
Senior
Full-time
Today
Associate Director, Regulatory Affairs CMC
Legal
South Boston, MA
On-site
Director
Full-time
Today
Closed positions
46 positions
Clinical Trial Associate
South Boston, MA
Entry
Closed 1 week ago
Associate Director, Clinical Scientist
South Boston, MA
Director
Closed 3 weeks ago
Research Associate II, CRISPR-X - LNP
South Boston, MA
Entry
Closed 1 month ago
Senior Manager, Alliance Management
South Boston, MA
Senior
Closed 1 month ago
Senior Engineer II, mRNA Process Development
South Boston, MA
Senior
Closed 1 month ago
Products and services
Exagamglogene Autotemcel (exa-cel) for Sickle Cell Disease
Gene Therapy
CT
CTX001
Gene Therapy
CT
CTX110
Immuno-oncology
CR
CRISPR Platform Technology
Platform Technology
CT
CTX130
Immuno-oncology
Exagamglogene Autotemcel (exa-cel) for β-thalassemia
Gene Therapy
TY
Type 1 Diabetes Program
Regenerative Medicine
CT
CTX131
Immuno-Oncology
CT
CTX120
Immuno-oncology
IN
In Vivo Gene Editing Platform
Gene Therapy
AU
Autoimmune Disease Programs
Autoimmune
HY
Hypoimmune Platform
Platform Technology
Leadership
DA
Daniel Anderson
Scientific Founders
SK
Stephen Kennedy
Head Of Technical Operations
RP
Raju Prasad
Chief Financial Officer
PKM
Phuong Khanh Morrow
Chief Medical Officer
Similar companies
Mammoth Biosciences
Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, our company’s ultracompact systems are…
Brisbane, San Mateo County
51-200 employees
Private
Valuation $800M
1 open jobs
BioNTech
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Mainz, Rhineland-Palatinate
1,001-5,000 employees
Public
Valuation $21.7B
114 open jobs
HCA Healthcare
Operates hospitals and healthcare facilities across the United States
Nashville, Davidson County
10,001+ employees
Public
Valuation $75B
42 open jobs
Invitae
Invitae and Labcorp together offer advanced genetic testing that can be easily integrated into medical practices.
San Francisco, California
501-1,000 employees
Private
13 open jobs
Medtronic
Develops medical technologies for complex health conditions
Fridley, Anoka County
10,001+ employees
Public
Valuation $100B
358 open jobs
Latest updates
All
X
News
HN
YouTube
Form 4 CRISPR Therapeutics AG: Samarth Kulkarni (Director, CEO) For: 13 October - Investing.com India
Investing.com India
News
·
1 week ago
Insider Selling: CRISPR Therapeutics (NASDAQ:CRSP) CEO Sells 4,098 Shares of Stock - MarketBeat
MarketBeat
News
·
1 week ago
CRISPR Therapeutics (NASDAQ:CRSP) General Counsel James Kasinger Sells 1,040 Shares of Company Stock - MarketBeat
MarketBeat
News
·
1 week ago
Tax withholding required CRISPR Therapeutics (CRSP) counsel to sell shares at $49.26 each. - Stock Titan
Stock Titan
News
·
1 week ago
After 8,333 shares vest, CRISPR Therapeutics (CRSP) CEO sells 4,098 for taxes. - Stock Titan
Stock Titan
News
·
1 week ago
Show 15 more
Total Views
122
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Reviews
3.2
95 reviews
Work-life balance
2.8
Compensation
3.2
Culture
3.0
Career
2.9
Management
2.5
46%
Recommend to a friend
Pros
Innovative projects
Good pay/compensation
Great team/colleagues
Cons
Work-life balance issues
Stressful/fast-paced environment
Management/leadership problems
Salary Ranges
70 data points
Mid/L4
1 reports
-
total per year
Base
$110,000
Stock
-
Contact and location